Literature DB >> 11593400

Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3.

M A McIlhatton1, J F Burrows, P G Donaghy, S Chanduloy, P G Johnston, S E Russell.   

Abstract

The Ov/Br septin gene, which is also a fusion partner of MLL in acute myeloid leukaemia, is a member of a family of novel GTP binding proteins that have been implicated in cytokinesis and exocytosis. In this study, we describe the genomic and transcriptional organization of this gene, detailing seventeen exons distributed over 240 kb of sequence. Extensive database analyses identified orthologous rodent cDNAs that corresponded to new, unidentified 5' splice variants of the Ov/Br septin gene, increasing the total number of such variants to six. We report that splicing events, occurring at non-canonical sites within the body of the 3' terminal exon, remove either 1801 bp or 1849 bp of non-coding sequence and facilitate access to a secondary open reading frame of 44 amino acids maintained near the end of the 3' UTR. These events constitute a novel coding arrangement and represent the first report of such a design being implemented by a eukaryotic gene. The various Ov/Br proteins either differ minimally at their amino and carboxy termini or are equivalent to truncated versions of larger isoforms. Northern analysis with an Ov/Br septin 3' UTR probe reveals three transcripts of 4.4, 4 and 3 kb, the latter being restricted to a sub-set of the tissues tested. Investigation of the identified Ov/Br septin isoforms by RT-PCR confirms a complex transcriptional pattern, with several isoforms showing tissue-specific distribution. To date, none of the other human septins have demonstrated such transcriptional complexity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593400     DOI: 10.1038/sj.onc.1204752

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis.

Authors:  Mark C Surka; Christopher W Tsang; William S Trimble
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

2.  Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.

Authors:  Alex D Chacko; Simon S McDade; Severine Chanduloy; Stewart W Church; Richard Kennedy; John Price; Peter A Hall; S E Hilary Russell
Journal:  Cell Oncol (Dordr)       Date:  2012-01-26       Impact factor: 6.730

Review 3.  Conquering the complex world of human septins: implications for health and disease.

Authors:  E A Peterson; E M Petty
Journal:  Clin Genet       Date:  2010-02-11       Impact factor: 4.438

4.  Mitotic regulation of SEPT9 protein by cyclin-dependent kinase 1 (Cdk1) and Pin1 protein is important for the completion of cytokinesis.

Authors:  Mathew P Estey; Caterina Di Ciano-Oliveira; Carol D Froese; Karen Y Y Fung; Jonathan D Steels; David W Litchfield; William S Trimble
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

5.  An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome.

Authors:  Lisa M Baumann Kreuziger; Julie Cliff Porcher; Rhett P Ketterling; David P Steensma
Journal:  Leuk Res       Date:  2007-01-23       Impact factor: 3.156

Review 6.  Septin functions in organ system physiology and pathology.

Authors:  Lee Dolat; Qicong Hu; Elias T Spiliotis
Journal:  Biol Chem       Date:  2014-02       Impact factor: 3.915

7.  Alternative splicing of sept9a and sept9b in zebrafish produces multiple mRNA transcripts expressed throughout development.

Authors:  Megan L Landsverk; Douglas C Weiser; Mark C Hannibal; David Kimelman
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

8.  Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.

Authors:  Esther A Peterson; Linda M Kalikin; Jonathan D Steels; Mathew P Estey; William S Trimble; Elizabeth M Petty
Journal:  Mamm Genome       Date:  2007-10-06       Impact factor: 2.957

9.  SEPT9 gene sequencing analysis reveals recurrent mutations in hereditary neuralgic amyotrophy.

Authors:  M C Hannibal; E K Ruzzo; L R Miller; B Betz; J G Buchan; D M Knutzen; K Barnett; M L Landsverk; A Brice; E LeGuern; H M Bedford; B B Worrall; S Lovitt; S H Appel; E Andermann; T D Bird; P F Chance
Journal:  Neurology       Date:  2009-05-19       Impact factor: 9.910

10.  Fusion of MLL and MSF in adult de novo acute myelomonocytic leukemia (M4) with t(11;17)(q23;q25).

Authors:  Koh Yamamoto; Fumi Shibata; Mitsuko Yamaguchi; Osamu Miura
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.